BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
Yes, even with the deal, the NHS can still refuse to buy drugs deemed too expensive or not cost-effective. The National Institute for Health and Care Excellence (NICE) assesses new medicines to decide if they offer good value for money. If a drug doesn't meet their criteria, the NHS isn't obliged to fund it, regardless of any broader agreement.
Stories that explain this
US-UK pharma deal could cost NHS 10,000 staff by 2028Related explainers
How much does the UK spend on drugs? Will my prescriptions get pricier? Will other countries pay more too? Will AI become more expensive globally? How does AI develop drugs? How does AI help drug discovery? Why is AI so expensive? Better NHS with AI?The full catalogue
Browse every card filed under N →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.